āĻুāĻুāϰ āĻ āĻŦিā§াāϞেāϰ āĻāύ্āϝ āĻāĻ āϤিāύāĻিāϰ āĻŽāϧ্āϝে “āĻāĻāĻাāĻ āϏেāϰা” āĻŦāϞা āĻ িāĻ āĻšāĻŦে āύা—āĻোāύ āĻীāĻŦাāĻŖু, āĻোāύ āϏংāĻ্āϰāĻŽāĻŖ, āĻĒ্āϰাāĻŖীāϰ āĻāĻāύ/āĻŦā§āϏ, āĻিāĻĄāύি-āϞিāĻাāϰেāϰ āĻ āĻŦāϏ্āĻĨা āĻāĻŦং āĻāĻেāϰ āĻ ্āϝাāύ্āĻিāĻŦাā§োāĻিāĻ āĻŦ্āϝāĻŦāĻšাāϰেāϰ āĻāĻĒāϰ āύিāϰ্āĻŦাāĻāύ āύিāϰ্āĻāϰ āĻāϰে।
āϤāĻŦে āĻāĻĒাāĻĻাāύ āĻ āĻŦ্āϝāĻŦāĻšাāϰ āĻ āύুāϝাā§ী āϤুāϞāύা āĻāϰāϞে:
| āĻāώুāϧ | āĻŽূāϞ āĻāĻĒাāĻĻাāύ | āĻুāĻুāϰ/āĻŦিā§াāϞে āĻĒ্āϰাāϏāĻ্āĻিāĻāϤা | āĻŽāύ্āϤāĻŦ্āϝ |
|---|---|---|---|
| Invemox 15% LA | Amoxicillin 150 mg/ml | ✅ āĻুāĻুāϰ āĻ āĻŦিā§াāϞেāϰ āĻāύ্āϝ āϏāϰাāϏāϰি āύিāĻŦāύ্āϧিāϤ āϤāĻĨ্āϝ āĻāĻে | āϏাāϧাāϰāĻŖ bacterial respiratory, skin/soft tissue, GI, urinary infection-āĻ āĻŦ্āϝāĻŦāĻšৃāϤ āĻšā§ (Medicines EU) |
| Combicillin-LA | Procaine Penicillin G + Benzathine Penicillin G + Dihydrostreptomycin | ⚠️ āĻŽূāϞāϤ cattle/pig-āĻāϰ āĻāύ্āϝ manufacturer indication | Penicillin/streptomycin-sensitive bacterial infection-āĻāϰ āĻāύ্āϝ; official product page-āĻ dog/cat āĻāϞ্āϞেāĻ āύেāĻ (Komipharm) |
| Eagle Long-PS | Procaine Penicillin G + Benzathine Penicillin G + Dihydrostreptomycin | ⚠️ āĻŽূāϞāϤ livestock product | āĻĻীāϰ্āĻ-āĻ ্āϝাāĻ্āĻিং penicillin + aminoglycoside; official indication livestock-āĻেāύ্āĻĻ্āϰিāĻ (Veterinary Medicine Directorate) |
đ āĻুāĻুāϰেāϰ āĻ্āώেāϤ্āϰে
āĻāĻ āϤিāύāĻিāϰ āĻŽāϧ্āϝে Invemox 15% LA-āϰ āĻĒāĻ্āώে āϏāĻŦāĻেā§ে āĻĒāϰিāώ্āĻাāϰ āϤāĻĨ্āϝ āĻĒাāĻā§া āϝাā§, āĻাāϰāĻŖ āĻāϰ product information-āĻ dogs āĻāĻŦং cats āĻāĻā§āĻেāĻ target species āĻšিāϏেāĻŦে āĻāϞ্āϞেāĻ āĻāϰা āĻšā§েāĻে। āĻāϤে amoxicillin 150 mg/ml āĻāĻে। (Medicines EU)
đ āĻŦিā§াāϞেāϰ āĻ্āώেāϤ্āϰে
āĻāĻāĻāĻাāĻŦে Invemox 15% LA-āϰ āĻ্āώেāϤ্āϰে cat-āĻāϰ āĻŦ্āϝāĻŦāĻšাāϰ product information-āĻ āϏāϰাāϏāϰি āĻāϞ্āϞেāĻ āĻāĻে। (Medicines EU)
⚠️ āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ āĻŦিāώā§
Eagle Long-PS āĻāĻŦং Combicillin-LA āĻāĻāĻ āϧāϰāύেāϰ combination-āĻāϰ āĻাāĻাāĻাāĻি—penicillin + dihydrostreptomycin। Eagle Long-PS-āĻāϰ āĻĒ্āϰāϤি mL-āϤে benzathine penicillin 100,000 IU + procaine penicillin 150,000 IU + dihydrostreptomycin 200 mg āϰā§েāĻে। (Eagle Vet)
āĻāϰ Combicillin-LA-āĻāϰ official manufacturer information cattle āĻ pig-āĻāϰ indication āĻĻেā§, dog/cat āύā§। (Komipharm)
āϤাāĻ āĻļুāϧু “āĻļāĻ্āϤিāĻļাāϞী” āĻ ্āϝাāύ্āĻিāĻŦাā§োāĻিāĻ āĻšিāϏেāĻŦে Eagle Long-PS āĻŦা Combicillin-LA āĻŦেāĻে āύেāĻā§া āĻāĻিāϤ āύā§। āĻŦিāĻļেāώ āĻāϰে āĻŦিā§াāϞেāϰ āĻ্āώেāϤ্āϰে aminoglycoside-containing combination-āĻāϰ āĻŦ্āϝāĻŦāĻšাāϰ veterinary supervision āĻাā§া āĻāϰা āĻ িāĻ āύā§।
āĻāĻĒāύি āϝāĻĻি āύিāĻāĻŽোāύিā§া, āϏāϰ্āĻĻি-āĻাāĻļি/āĻļ্āĻŦাāϏāύাāϞীāϰ āϏংāĻ্āϰāĻŽāĻŖ, āĻ্āĻŦāϰ, āĻ্āώāϤ/āĻĒুঁāĻ, skin infection āĻāĻŦং urinary infection—āĻāĻ āĻā§ āϧāϰāύেāϰ āϏāĻŽāϏ্āϝাāϰ āĻāύ্āϝ āĻāĻ āϤিāύāĻি āĻāύāĻেāĻāĻļāύেāϰ āϤুāϞāύা āĻাāύ, āϤাāĻšāϞে āĻŽূāϞ āĻŦিāώ⧠āĻšāϞো āĻোāύ āĻীāĻŦাāĻŖুāϰ āĻŦিāϰুāĻĻ্āϧে āĻāώুāϧāĻি āĻাāĻ āĻāϰাāϰ āϏāĻŽ্āĻাāĻŦāύা āĻŦেāĻļি āĻāĻŦং āĻĒ্āϰাāĻŖীāĻিāϰ āĻāύ্āϝ āĻāϤāĻা āύিāϰাāĻĒāĻĻ।
āϤুāϞāύাāĻŽূāϞāĻāĻাāĻŦে
| āϏāĻŽāϏ্āϝা | Invemox 15% LA | Combicillin-LA | Eagle Long-PS |
|---|---|---|---|
| đĢ āύিāĻāĻŽোāύিā§া | ✅ āĻŦ্āϝāĻŦāĻšাāϰāϝোāĻ্āϝ, āϝāĻĻি āĻীāĻŦাāĻŖু amoxicillin-sensitive āĻšā§ | ⚠️ āύিāϰ্āĻĻিāώ্āĻ āĻ্āώেāϤ্āϰে | ⚠️ āύিāϰ্āĻĻিāώ্āĻ āĻ্āώেāϤ্āϰে |
| 𤧠āĻŦ্āϝাāĻāĻেāϰিā§াāϞ āϏāϰ্āĻĻি-āĻাāĻļি | ✅ | ⚠️ | ⚠️ |
| đĄ️ āĻ্āĻŦāϰ | đļ āĻাāϰāĻŖ āĻŦ্āϝাāĻāĻেāϰিā§াāϞ āĻšāϞে | đļ | đļ |
| 𩹠āĻ্āώāϤ/āĻĒুঁāĻ | ✅ | ⚠️ | ⚠️ |
| đ Skin infection | ✅ | ⚠️ | ⚠️ |
| đŊ Urinary infection | ✅ āϏāĻŽ্āĻাāĻŦ্āϝ āĻŦ্āϝāĻŦāĻšাāϰ | ⚠️ | ⚠️ |
Invemox 15% LA = amoxicillin 150 mg/mL, āĻāĻŦং product information-āĻ respiratory, urogenital, skin/soft-tissue āĻāĻŦং āĻ āύ্āϝাāύ্āϝ susceptible bacterial infection-āĻāϰ āĻāĻĨা āĻāϞ্āϞেāĻ āĻāĻে; āĻিāĻু product information-āĻ dogs āĻ cats-āĻে target species āĻšিāϏেāĻŦেāĻ āĻāϞ্āϞেāĻ āĻāϰা āĻšā§েāĻে। (Alivira)
đđ āĻŦিāĻļেāώ āĻāϰে āĻুāĻুāϰ āĻ āĻŦিā§াāϞেāϰ āĻāύ্āϝ
āĻāĻ āϤিāύāĻিāϰ āĻŽāϧ্āϝে Invemox 15% LA-āĻে āϤুāϞāύাāĻŽূāϞāĻāĻাāĻŦে āĻŦেāĻļি āϝৌāĻ্āϤিāĻ āĻĒāĻāύ্āĻĻ āĻšিāϏেāĻŦে āĻŦিāĻŦেāĻāύা āĻāϰা āϝাā§, āϝāĻĻি āϰোāĻāĻি āϏāϤ্āϝিāĻ amoxicillin-sensitive bacterial infection āĻšā§।
āϤāĻŦে āĻāĻāĻা āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ āĻŦিāώā§: “āύিāĻāĻŽোāύিā§া = Invemox” āĻāĻŽāύ āϏāϰāϞ āύিā§āĻŽ āύেāĻ। āύিāĻāĻŽোāύিā§া āĻাāĻāϰাāϏ, aspiration, resistant bacteria āĻŦা āĻ āύ্āϝ āĻাāϰāĻŖেāĻ āĻšāϤে āĻĒাāϰে। Amoxicillin beta-lactamase-producing bacteria-āĻāϰ āĻŦিāϰুāĻĻ্āϧে āĻাāϰ্āϝāĻāϰ āύ⧠āĻāĻŦং resistance āĻĨাāĻāϞে āĻĢāϞ āĻāĻŽে āϝেāϤে āĻĒাāϰে। (GOV.UK)
⚠️ Eagle Long-PS / Combicillin-LA āϏāĻŽ্āĻĒāϰ্āĻে āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ āϏāϤāϰ্āĻāϤা
āĻāĻ āϧāϰāύেāϰ combination-āĻ dihydrostreptomycin āĻĨাāĻে। Aminoglycoside āĻļ্āϰেāĻŖিāϰ āĻāώুāϧে kidney toxicity (nephrotoxicity) āĻāĻŦং āĻ āύ্āϝাāύ্āϝ toxicity-āĻāϰ āĻুঁāĻি āĻĨাāĻে; dehydration, kidney disease āĻāĻŦং āĻিāĻু āĻ āύ্āϝ āĻāώুāϧেāϰ āϏāĻ্āĻে āĻুঁāĻি āĻāϰāĻ āĻŦাā§āϤে āĻĒাāϰে। (Merck Veterinary Manual)
āϤাāĻ āĻŦিāĻļেāώ āĻāϰে āĻŦā§āϏ্āĻ, āĻĒাāύিāĻļূāύ্āϝ, āĻিāĻĄāύি āϏāĻŽāϏ্āϝাāϝুāĻ্āϤ āĻŦা āĻুāϰুāϤāϰ āĻ āϏুāϏ্āĻĨ āĻুāĻুāϰ/āĻŦিā§াāϞেāϰ āĻ্āώেāϤ্āϰে āĻāĻুāϞো āύিāĻেāϰ āϏিāĻĻ্āϧাāύ্āϤে āĻĻেāĻā§া āĻāĻিāϤ āύā§।
āĻāϰেāĻāĻি āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ āĻŦিāώā§: āϤিāύāĻি āĻāώুāϧেāϰāĻ āĻĄোāĻ/āĻŦ্āϝāĻŦāĻšাāϰেāϰ āύিā§āĻŽ āĻāĻ āύā§। āϤাāĻ āĻļুāϧু vial-āĻāϰ strength āĻĻেāĻে āĻāĻāĻ mL/10 kg āϧāϰে āύেāĻā§া āύিāϰাāĻĒāĻĻ āύā§।
āĻāĻĒāύি āĻাāĻāϞে āĻāĻŽি āĻĒāϰেāϰ āϧাāĻĒে đ āĻুāĻুāϰ āĻ đ āĻŦিā§াāϞেāϰ āĻāύ্āϝ āĻāϞাāĻĻা āĻāϰে āĻāĻ ā§ŦāĻি āϰোāĻে—
āĻোāύ antibiotic āϏাāϧাāϰāĻŖāϤ āĻĒ্āϰāĻĨāĻŽে āĻŦিāĻŦেāĻāύা āĻāϰা āĻšā§ + Invemox/Combicillin/Eagle Long-PS-āĻāϰ āĻূāĻŽিāĻা + āĻāĻāύ culture/sensitivity āĻĻāϰāĻাāϰ + āĻāĻāύ āĻāϰুāϰি vet treatment āĻĻāϰāĻাāϰ—āĻāĻāĻি āĻŦিāϏ্āϤাāϰিāϤ āĻাāϰ্āĻ āĻāϰে āĻĻিāϤে āĻĒাāϰি।
āĻ āĻŦāĻļ্āϝāĻ। āύিāĻেāϰ āĻাāϰ্āĻāĻি āĻুāĻুāϰ āĻ āĻŦিā§াāϞেāϰ āĻ্āώেāϤ্āϰে āĻāĻ āϤিāύāĻি āĻāύāĻেāĻāĻļāύেāϰ āϏāĻŽ্āĻাāĻŦ্āϝ āĻূāĻŽিāĻা āĻŦোāĻাāύোāϰ āĻāύ্āϝ। āĻāĻি āĻĒ্āϰেāϏāĻ্āϰিāĻĒāĻļāύ āύ⧗āĻŦিāĻļেāώ āĻāϰে āĻāύāĻেāĻāĻļāύ āĻ ্āϝাāύ্āĻিāĻŦাā§োāĻিāĻ āĻĻেāĻā§াāϰ āĻāĻে āϰোāĻ āύিāϰ্āĻŖā§ āĻ āĻĒ্āϰাāĻŖীāϰ āĻāĻāύ/āĻিāĻĄāύি-āϞিāĻাāϰ āĻ āĻŦāϏ্āĻĨা āĻŦিāĻŦেāĻāύা āĻāϰা āĻāϰুāϰি।
đđ āϰোāĻāĻিāϤ্āϤিāĻ āĻŦিāϏ্āϤাāϰিāϤ āĻাāϰ্āĻ
| āϏāĻŽāϏ্āϝা | Invemox 15% LA | Combicillin-LA | Eagle Long-PS | āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ āĻŦিāώ⧠|
|---|---|---|---|---|
| đĢ āĻŦ্āϝাāĻāĻেāϰিā§াāϞ āύিāĻāĻŽোāύিā§া | đĸ āϏāĻŽ্āĻাāĻŦ্āϝ | đĄ āύিāϰ্āĻĻিāώ্āĻ āĻ্āώেāϤ্āϰে | đĄ āύিāϰ্āĻĻিāώ্āĻ āĻ্āώেāϤ্āϰে | āĻুāϰুāϤāϰ pneumonia-āϤে āĻļুāϧু āĻāĻāĻি LA injection āϝāĻĨেāώ্āĻ āύাāĻ āĻšāϤে āĻĒাāϰে |
| 𤧠āĻŦ্āϝাāĻāĻেāϰিā§াāϞ āϏāϰ্āĻĻি-āĻাāĻļি/URI | đĸ āϏāĻŽ্āĻাāĻŦ্āϝ | đĄ | đĄ | āĻ āύেāĻ respiratory infection āĻাāĻāϰাāϏ/āĻ āύ্āϝাāύ্āϝ āĻীāĻŦাāĻŖুāĻāύিāϤ; antibiotic āϏāĻŦāϏāĻŽā§ āĻĻāϰāĻাāϰ āĻšā§ āύা |
| đĄ️ āĻ্āĻŦāϰ | đĄ āĻাāϰāĻŖ āĻŦ্āϝাāĻāĻেāϰিā§াāϞ āĻšāϞে | đĄ | đĄ | āĻ্āĻŦāϰ āύিāĻে antibiotic-āĻāϰ indication āύ⧠|
| 𩹠āĻ্āώāϤ + āĻĒুঁāĻ | đĸ āϏāĻŽ্āĻাāĻŦ্āϝ | đĄ | đĄ | abscess āĻšāϞে drainage/cleaning āĻ āϤ্āϝāύ্āϤ āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ |
| đ Skin infection | đĸ āϏāĻŽ্āĻাāĻŦ্āϝ | đĄ | đĄ | superficial āĻŦāύাāĻŽ deep infection āĻāϞাāĻĻা |
| đŊ UTI/cystitis | đĸ āϏāĻŽ্āĻাāĻŦ্āϝ | đĄ | đĄ | urine test/culture āĻāϰāϞে antibiotic āύিāϰ্āĻŦাāĻāύ āĻ āύেāĻ āĻŦেāĻļি āύিāϰ্āĻুāϞ āĻšā§ |
| đĢ Kidney infection/pyelonephritis | đ´ āύিāĻে āĻĨেāĻে āύ⧠| đ´ āύিāĻে āĻĨেāĻে āύ⧠| đ´ āύিāĻে āĻĨেāĻে āύ⧠| culture āĻ veterinary assessment āĻĒ্āϰā§োāĻāύ |
| 𩸠Sepsis/āĻ āϤ্āϝāύ্āϤ āĻুāϰুāϤāϰ infection | đ´ āĻāĻা āϝāĻĨেāώ্āĻ āϧāϰে āύেāĻā§া āϝাāĻŦে āύা | đ´ | đ´ | āĻšাāϏāĻĒাāϤাāϞে/āĻāϰুāϰি veterinary treatment āĻĒ্āϰā§োāĻāύ |
đĸ = āĻিāĻু āĻĒāϰিāϏ্āĻĨিāϤিāϤে āĻŦ্āϝāĻŦāĻšাāϰāϝোāĻ্āϝ
đĄ = āύিāϰ্āĻĻিāώ্āĻ āĻĒāϰিāϏ্āĻĨিāϤিāϤে/āĻেāĻেāϰিāύাāϰিāϰ āϏিāĻĻ্āϧাāύ্āϤে
đ´ = āύিāĻে āĻĨেāĻে āĻŦ্āϝāĻŦāĻšাāϰ āĻāϰা āĻāĻিāϤ āύā§
āĻেāύ Invemox āϤুāϞāύাāĻŽূāϞāĻāĻাāĻŦে āĻŦেāĻļি āĻĒ্āϰাāϏāĻ্āĻিāĻ?
Invemox 15% LA-āĻāϰ active ingredient amoxicillin। Amoxicillin susceptible bacterial infection-āĻ āĻŦ্āϝāĻŦāĻšাāϰ āĻāϰা āĻšā§ āĻāĻŦং respiratory āĻ urinary infection-āϏāĻš āĻŦিāĻিāύ্āύ bacterial infection-āĻ veterinary medicine-āĻ āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ āĻāĻāĻি antibiotic। āϤāĻŦে beta-lactamase-producing bacteria, āĻ āύেāĻ Bordetella, Mycoplasma āĻāĻŦং āĻিāĻু āĻ āύ্āϝাāύ্āϝ āĻীāĻŦাāĻŖুāϰ āĻŦিāϰুāĻĻ্āϧে āĻāĻি āĻাāĻ āύাāĻ āĻāϰāϤে āĻĒাāϰে। (DOI)
āĻ āύ্āϝāĻĻিāĻে Eagle Long-PS/Combicillin-LA āϧāϰāύেāϰ penicillin + dihydrostreptomycin combination-āĻ aminoglycoside āĻļ্āϰেāĻŖিāϰ āĻāώুāϧ āĻĨাāĻে। Aminoglycoside-āĻāϰ āĻ্āώেāϤ্āϰে kidney toxicity-āĻāϰ āĻŦিāώā§āĻি āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ, āĻŦিāĻļেāώ āĻāϰে dehydrated āĻŦা renal disease āĻĨাāĻা āĻĒ্āϰাāĻŖীāϤে। (Merck Veterinary Manual)
đĢ ā§§. āύিāĻāĻŽোāύিā§া
āĻāĻাāύে āϏāĻŦāĻেā§ে āĻŦেāĻļি āϏāϤāϰ্āĻāϤা āĻĻāϰāĻাāϰ।
āύিāĻāĻŽোāύিā§া āĻšāϤে āĻĒাāϰে:
bacterial
viral
aspiration
fungal
parasitic
āĻ āύ্āϝ respiratory disease-āĻāϰ secondary complication
āϤাāĻ āĻļুāϧু āĻ্āĻŦāϰ + āĻাāĻļি āĻĻেāĻেāĻ antibiotic āύিāϰ্āĻŦাāĻāύ āĻāϰা āĻ িāĻ āύā§। (Merck Veterinary Manual)
Veterinary respiratory guidelines āĻ āύুāϝাā§ী uncomplicated bacterial respiratory disease-āĻ amoxicillin āĻŦা amoxicillin-clavulanate āĻিāĻু āĻ্āώেāϤ্āϰে āĻŦ্āϝāĻŦāĻšৃāϤ āĻšā§; āĻিāύ্āϤু pneumonia-āĻāϰ āϏāĻ্āĻে sepsis/āĻুāϰুāϤāϰ systemic illness āĻĨাāĻāϞে injectable/combination therapy āĻāĻŦং culture-guided treatment āĻĒ্āϰā§োāĻāύ āĻšāϤে āĻĒাāϰে। (DOI)
āĻŦিāĻļেāώ āϏāϤāϰ্āĻāϤা:
āĻļ্āĻŦাāϏ āύিāϤে āĻāώ্āĻ, āύীāϞ/āϧূāϏāϰ āĻিāĻš্āĻŦা āĻŦা āĻŽাā§ি, āĻুāĻŦ āĻĻ্āϰুāϤ āĻļ্āĻŦাāϏ, āĻĻাঁā§িā§ে āĻĨাāĻāϤে āύা āĻĒাāϰা, severe lethargy āĻĨাāĻāϞে āĻŦাā§িāϤে āĻāύāĻেāĻāĻļāύ āĻĻিā§ে āĻ
āĻĒেāĻ্āώা āύা āĻāϰে āĻāϰুāϰি veterinary care āĻĒ্āϰā§োāĻāύ। Hypoxemia āĻĨাāĻāϞে oxygen therapy āĻĻāϰāĻাāϰ āĻšāϤে āĻĒাāϰে। (Merck Veterinary Manual)
đ¤§ ā§¨. āϏāϰ্āĻĻি-āĻাāĻļি / URI
āĻāĻাāύে antibiotic āĻĻেāĻā§াāϰ āĻāĻে viral āĻŦāύাāĻŽ bacterial āĻাāϰāĻŖ āĻŦিāĻŦেāĻāύা āĻāϰা āĻāĻিāϤ।
āĻŦিā§াāϞে: acute bacterial upper respiratory infection-āĻāϰ āĻ্āώেāϤ্āϰে doxycycline āĻŦা amoxicillin guideline-supported options-āĻāϰ āĻŽāϧ্āϝে āĻāĻে, āϤāĻŦে Mycoplasma āĻŦা Chlamydia felis āϏāύ্āĻĻেāĻš āĻšāϞে amoxicillin āĻāĻĒāϝুāĻ্āϤ āύাāĻ āĻšāϤে āĻĒাāϰে। (DOI)
āĻুāĻুāϰে: bacterial component āĻĨাāĻāϞে amoxicillin-clavulanate āĻŦা doxycycline āĻ āύেāĻ āĻ্āώেāϤ্āϰে āĻŦিāĻŦেāĻāύা āĻāϰা āĻšā§। (DOI)
đŠš ā§Š. āĻ্āώāϤ / āĻĒুঁāĻ
āĻāĻাāύে āĻāĻāĻি āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ āĻুāϞ āĻā§াāύো āĻĻāϰāĻাāϰ:
āĻļুāϧু antibiotic injection āĻĻিā§ে abscess āĻাāϞো āύাāĻ āĻšāϤে āĻĒাāϰে।
āĻĒুঁāĻ āĻāĻŽে āĻĨাāĻāϞে āϏাāϧাāϰāĻŖāϤ veterinary examination, āϝāĻĨাāϝāĻĨ drainage/cleaning āĻāĻŦং āĻĒ্āϰā§োāĻāύে culture āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ।
Amoxicillin susceptible bacteria-āĻāϰ āĻ্āώেāϤ্āϰে āĻাāĻে āϞাāĻāϤে āĻĒাāϰে, āĻিāύ্āϤু resistant organism āĻĨাāĻāϞে āĻ āύ্āϝ antibiotic āĻĒ্āϰā§োāĻāύ āĻšāϤে āĻĒাāϰে।
đ ā§Ē. Skin infection
Skin infection-āĻāϰ āϧāϰāύ āύিāϰ্āĻŖā§ āĻāϰা āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ:
Superficial bacterial dermatitis → āĻāĻāĻি treatment approach
Deep pyoderma/abscess → āĻিāύ্āύ approach
Fungal infection → antibiotic āĻাāĻ āĻāϰāĻŦে āύা
Mite/allergy-related lesion → antibiotic āĻŽূāϞ āĻাāϰāĻŖ āĻ িāĻ āĻāϰāĻŦে āύা
āϤাāĻ āĻļুāϧু “āĻাāĻŽā§াā§ āĻĒুঁāĻ āĻāĻে = Combicillin/Eagle/Invemox” āĻāϰা āĻ িāĻ āύā§।
đŊ ā§Ģ. Urinary infection
āĻāĻাāύে amoxicillin āĻāĻāĻি āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ option āĻšāϤে āĻĒাāϰে। Veterinary UTI guidelines uncomplicated UTI-āϤে amoxicillin-āĻে first-line options-āĻāϰ āĻŽāϧ্āϝে āϰাāĻে। (PubMed Central (PMC))
āϤāĻŦে recurrent UTI, male cat/dog, kidney involvement, obstruction, fever āĻŦা treatment failure āĻĨাāĻāϞে urinalysis + urine culture/sensitivity āĻ āύেāĻ āĻŦেāĻļি āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ। (PubMed Central (PMC))
āĻŦিāĻļেāώ āĻāϰে male cat đ¨
āϝāĻĻি āĻŦিā§াāϞ āĻŦাāϰāĻŦাāϰ litter box-āĻ āϝাā§ āĻিāύ্āϤু urine āĻŦেāϰ āĻāϰāϤে āύা āĻĒাāϰে, āĻŦ্āϝāĻĨাā§ āĻাঁāĻĻে, āĻ āϏ্āĻĨিāϰ āĻšā§ āĻŦা āĻļুāϧু āĻā§েāĻ āĻĢোঁāĻা urine āĻāϏে—āĻāĻি urinary obstruction-āĻāϰ emergency āĻšāϤে āĻĒাāϰে। āϤāĻāύ antibiotic injection āĻĻিā§ে āĻ āĻĒেāĻ্āώা āĻāϰা āĻŦিāĻĒāĻ্āĻāύāĻ।
đ āϤাāĻšāϞে āĻāĻĒāύাāϰ āϤিāύāĻিāϰ āĻŽāϧ্āϝে āĻীāĻাāĻŦে āĻাāĻŦāĻŦেāύ?
āĻļুāϧু āĻāĻ āϤিāύāĻি āĻĒāĻŖ্āϝেāϰ āĻŽāϧ্āϝে āύিāϰ্āĻŦাāĻāύ āĻāϰāϤে āĻšāϞে:
đ āĻুāĻুāϰ
Invemox 15% LA → āϤুāϞāύাāĻŽূāϞāĻāĻাāĻŦে āĻŦেāĻļি āĻĒ্āϰাāϏāĻ্āĻিāĻ
āĻŦিāĻļেāώ āĻāϰে susceptible bacterial respiratory/skin/soft-tissue/urinary infection-āĻāϰ āĻ্āώেāϤ্āϰে।
đ āĻŦিā§াāϞ
Invemox 15% LA → āϤুāϞāύাāĻŽূāϞāĻāĻাāĻŦে āĻŦেāĻļি āĻĒ্āϰাāϏāĻ্āĻিāĻ, āĻিāύ্āϤু respiratory infection-āĻāϰ āĻীāĻŦাāĻŖু āĻ āύুāϝাā§ী doxycycline āĻŦা āĻ āύ্āϝ antibiotic āĻŦেāĻļি āĻāĻĒāϝুāĻ্āϤ āĻšāϤে āĻĒাāϰে। (DOI)
⚠️ Combicillin-LA / Eagle Long-PS
āĻāĻুāϞোāĻে “āĻāϰāĻ āĻļāĻ্āϤিāĻļাāϞী, āϤাāĻ āĻāϰāĻ āĻাāϞো” āϧāϰে āύেāĻā§া āĻ িāĻ āύā§। āĻŦিāĻļেāώ āĻāϰে dihydrostreptomycin-containing products-āĻāϰ āĻ্āώেāϤ্āϰে renal safety āĻŦিāĻŦেāĻāύা āĻāϰা āĻāϰুāϰি। (Merck Veterinary Manual)
āĻāϰেāĻāĻি āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ āĻŦিāώā§: āĻāĻ āϤিāύāĻিāϰ āĻŽāϧ্āϝে āĻোāύো āĻāĻāĻি āĻāύāĻেāĻāĻļāύāĻে āĻāĻŽি āϏāĻŦ āĻā§āĻি āϰোāĻেāϰ āĻāύ্āϝ “āϏেāϰা” āĻŦāϞāĻŦ āύা। Antibiotic selection ideally infection site, suspected organism, culture/sensitivity āĻāĻŦং āĻĒ্āϰাāĻŖীāϰ clinical condition āĻ āύুāϝাā§ী āĻšāĻā§া āĻāĻিāϤ। Pneumonia-āϤে 48–72 āĻāĻŖ্āĻাā§ response āύা āĻĨাāĻāϞে treatment reassessment āĻĒ্āϰā§োāĻāύ। (Merck Veterinary Manual)
Invemox 15% LA-āϤে amoxicillin 150 mg/mL āĻāĻŦং āĻুāĻুāϰ-āĻŦিā§াāϞ target species āĻšিāϏেāĻŦে āĻāϞ্āϞেāĻ āĻāĻে। āĻŦাংāϞাāĻĻেāĻļি veterinary drug references-āĻ 1 mL/10 kg, IM/SC, 48 āĻāĻŖ্āĻা āĻĒāϰ āĻĒ্āϰā§োāĻāύে repeat āĻĻেāĻā§া āĻāĻে; āĻ āύ্āϝ āĻĻেāĻļেāϰ Invemox label-āĻ āĻāĻŦাāϰ 5–10 mg/kg range āĻĒাāĻā§া āϝাā§। āϤাāĻ āĻāĻĒāύাāϰ āĻšাāϤে āĻĨাāĻা ACI/āĻŦাংāϞাāĻĻেāĻļেāϰ vial-āĻāϰ label-āĻে āĻ āĻ্āϰাāϧিāĻাāϰ āĻĻেāĻā§া āĻāĻিāϤ। (Scribd)
đđ Invemox 15% LA — āĻāĻāύāĻিāϤ্āϤিāĻ āĻাāϰ্āĻ
āϝāĻĻি āĻāĻĒāύাāϰ vial-āĻāϰ āύিāϰ্āĻĻেāĻļāύা 1 mL/10 kg (15 mg/kg), 48 āĻāĻŖ্āĻা interval āĻšā§:
| āĻāĻāύ | Amoxicillin dose | Invemox 15% LA volume |
|---|---|---|
| 1 kg | 15 mg | 0.10 mL |
| 2 kg | 30 mg | 0.20 mL |
| 3 kg | 45 mg | 0.30 mL |
| 5 kg | 75 mg | 0.50 mL |
| 10 kg | 150 mg | 1.00 mL |
| 15 kg | 225 mg | 1.50 mL |
| 20 kg | 300 mg | 2.00 mL |
| 25 kg | 375 mg | 2.50 mL |
| 30 kg | 450 mg | 3.00 mL |
āĻšিāϏাāĻŦ: 150 mg/mL × 0.1 mL/kg = 15 mg/kg।
⏱️ āĻāϤ āĻāĻŖ্āĻা āĻĒāϰ?
48 āĻāĻŖ্āĻা āĻĒāϰ āĻĒ্āϰā§োāĻāύ āĻšāϞে repeat āĻāϰাāϰ āύিāϰ্āĻĻেāĻļāύা āĻĒাāĻā§া āϝাā§। āĻ āϰ্āĻĨাā§ āĻāĻি āϏাāϧাāϰāĻŖāϤ āĻĒ্āϰāϤিāĻĻিāύ āĻĻেāĻā§াāϰ injection āύā§। (Alivira)
đ āϏāϰ্āĻŦোāĻ্āĻ āĻāϤāĻĻিāύ?
āĻāĻাāύে product information-āĻ āĻĒাāϰ্āĻĨāĻ্āϝ āĻāĻে। āĻāĻāĻি Invemox 15% LA label āϏāϰ্āĻŦোāĻ্āĻ 5 āĻĻিāύ āĻāĻŦং 48 āĻāĻŖ্āĻাāϰ āĻŽāϧ্āϝে āĻāύ্āύāϤি āύা āĻšāϞে diagnosis āĻĒুāύāϰ্āĻŽূāϞ্āϝাā§āύেāϰ āĻāĻĨা āĻŦāϞে। (Veterinaria Alvear)
āϤাāĻ āύিāĻে āĻĨেāĻে 5 āĻĻিāύেāϰ āĻŦেāĻļি āĻাāϞাāύো āĻāĻিāϤ āύā§। 48 āĻāĻŖ্āĻাā§ āĻāύ্āύāϤি āύা āĻšāϞে āĻŦিāĻļেāώ āĻāϰে pneumonia, fever āĻŦা pus/abscess-āĻāϰ āĻ্āώেāϤ্āϰে āϰোāĻ āύিāϰ্āĻŖā§ āĻ antibiotic āύিāϰ্āĻŦাāĻāύ āĻāĻŦাāϰ āĻĒāϰীāĻ্āώা āĻāϰা āĻĻāϰāĻাāϰ।
đ āĻŦāύাāĻŽ đ
āĻāĻ 15 mg/kg calculation āĻুāĻুāϰ āĻ āĻŦিā§াāϞ āĻāĻā§েāϰ āĻāύ্āϝ āĻāĻāĻ, āĻাāϰāĻŖ product information-āĻ āĻĻুāĻ species-āĻ āĻ āύ্āϤāϰ্āĻুāĻ্āϤ। āϤāĻŦে āĻোāύ āϰোāĻে āĻāĻĻৌ amoxicillin āĻāĻĒāϝুāĻ্āϤ āĻিāύা—āϏেāĻি āĻুāĻুāϰ āĻ āĻŦিā§াāϞেāϰ āĻ্āώেāϤ্āϰে āĻāĻ āύā§। (Akvmb)
āĻুāĻŦ āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ: 1–3 kg āĻŦিā§াāϞ/āĻোāĻ āĻুāĻুāϰে 0.1–0.3 mL-āĻāϰ āĻŽāϤো āĻোāĻ volume āĻŽাāĻĒাāϰ āĻāύ্āϝ 1-mL syringe āĻŦ্āϝāĻŦāĻšাāϰ āĻāϰা āĻŦেāĻļি āύিāϰ্āĻুāϞ। āĻāύāĻেāĻāĻļāύ IV āĻĻেāĻā§া āϝাāĻŦে āύা; product information āĻ āύুāϝাā§ী IM āĻŦা SC route āĻŦ্āϝāĻŦāĻšৃāϤ āĻšā§। (Veterinaria Alvear)
āĻāϰ penicillin allergy-āĻāϰ āĻāϤিāĻšাāϏ āĻĨাāĻāϞে āĻŦ্āϝāĻŦāĻšাāϰ āĻāϰা āϝাāĻŦে āύা। āĻুāϰুāϤāϰ pneumonia, āĻļ্āĻŦাāϏāĻāώ্āĻ, āĻুāĻŦ āĻŦেāĻļি āĻ্āĻŦāϰ, āĻĻুāϰ্āĻŦāϞāϤা āĻŦা dehydration āĻĨাāĻāϞে āĻāĻ chart āĻ āύুāϏāϰāĻŖ āĻāϰে āĻŦাā§িāϤে āĻিāĻিā§āϏা āύা āĻāϰে veterinarian-āĻāϰ assessment āĻāϰুāϰি।
āĻāĻĒāύি āĻাāĻāϞে āĻāĻŽি āĻāĻāύ ā§§–ā§Šā§Ļ āĻেāĻি āĻুāĻুāϰ āĻ ā§Ļ.ā§Ģ–ā§Ž āĻেāĻি āĻŦিā§াāϞেāϰ āĻāύ্āϝ āĻāϞাāĻĻা āĻĒূāϰ্āĻŖ Invemox 15% LA dose chart, āϏāĻ্āĻে pneumonia/skin infection/UTI/āĻ্āώāϤ-āĻĒুঁāĻ āĻ āύুāϝাā§ী āĻāϤ dose āĻ āĻāĻāύ culture āĻĻāϰāĻাāϰ—āĻāĻāĻি āĻŦ্āϝāĻŦāĻšাāϰāϝোāĻ্āϝ āĻেāĻŦিāϞ āĻŦাāύিā§ে āĻĻিāϤে āĻĒাāϰি।
āĻ āĻŦāĻļ্āϝāĻ। Invemox 15% LA = amoxicillin 150 mg/mL। āĻāĻŽি āϝে product information āĻĒেāϞাāĻŽ, āϏেāĻাāύে āĻুāĻুāϰ āĻ āĻŦিā§াāϞেāϰ āĻāύ্āϝ 15 mg/kg = 1 mL/10 kg, IM āĻŦা SC, āĻĒ্āϰā§োāĻāύে 48 āĻāĻŖ্āĻা āĻĒāϰে āĻāĻāĻŦাāϰ repeat āĻāϰাāϰ āύিāϰ্āĻĻেāĻļāύা āĻāĻে। āĻŦাংāϞাāĻĻেāĻļি veterinary references-āĻ Invemox 15% LA-āĻāϰ āĻāύ্āϝ āĻāĻāĻ 1 mL/10 kg, 48-hour interval āĻāϞ্āϞেāĻ āĻāϰে। (Medicines EU)
āύিāĻেāϰ āĻাāϰ্āĻāĻি 15 mg/kg dose-āĻāϰ āĻāĻŖāύা। āĻāĻি āϰোāĻ āύিāϰ্āĻŖā§ āĻŦা āĻŦ্āϝāĻ্āϤিāĻāϤ veterinary prescription-āĻāϰ āĻŦিāĻāϞ্āĻĒ āύā§।
đ āĻুāĻুāϰ — ā§§–ā§Šā§Ļ kg
| āĻāĻāύ | Amoxicillin 15 mg/kg | Invemox 15% LA |
|---|---|---|
| 1 kg | 15 mg | 0.10 mL |
| 2 kg | 30 mg | 0.20 mL |
| 3 kg | 45 mg | 0.30 mL |
| 4 kg | 60 mg | 0.40 mL |
| 5 kg | 75 mg | 0.50 mL |
| 6 kg | 90 mg | 0.60 mL |
| 7 kg | 105 mg | 0.70 mL |
| 8 kg | 120 mg | 0.80 mL |
| 9 kg | 135 mg | 0.90 mL |
| 10 kg | 150 mg | 1.00 mL |
| 11 kg | 165 mg | 1.10 mL |
| 12 kg | 180 mg | 1.20 mL |
| 13 kg | 195 mg | 1.30 mL |
| 14 kg | 210 mg | 1.40 mL |
| 15 kg | 225 mg | 1.50 mL |
| 16 kg | 240 mg | 1.60 mL |
| 17 kg | 255 mg | 1.70 mL |
| 18 kg | 270 mg | 1.80 mL |
| 19 kg | 285 mg | 1.90 mL |
| 20 kg | 300 mg | 2.00 mL |
| 21 kg | 315 mg | 2.10 mL |
| 22 kg | 330 mg | 2.20 mL |
| 23 kg | 345 mg | 2.30 mL |
| 24 kg | 360 mg | 2.40 mL |
| 25 kg | 375 mg | 2.50 mL |
| 26 kg | 390 mg | 2.60 mL |
| 27 kg | 405 mg | 2.70 mL |
| 28 kg | 420 mg | 2.80 mL |
| 29 kg | 435 mg | 2.90 mL |
| 30 kg | 450 mg | 3.00 mL |
đ āĻŦিā§াāϞ — ā§Ļ.ā§Ģ–ā§Ž kg
| āĻāĻāύ | Amoxicillin 15 mg/kg | Invemox 15% LA |
|---|---|---|
| 0.5 kg | 7.5 mg | 0.05 mL |
| 1.0 kg | 15 mg | 0.10 mL |
| 1.5 kg | 22.5 mg | 0.15 mL |
| 2.0 kg | 30 mg | 0.20 mL |
| 2.5 kg | 37.5 mg | 0.25 mL |
| 3.0 kg | 45 mg | 0.30 mL |
| 3.5 kg | 52.5 mg | 0.35 mL |
| 4.0 kg | 60 mg | 0.40 mL |
| 4.5 kg | 67.5 mg | 0.45 mL |
| 5.0 kg | 75 mg | 0.50 mL |
| 5.5 kg | 82.5 mg | 0.55 mL |
| 6.0 kg | 90 mg | 0.60 mL |
| 6.5 kg | 97.5 mg | 0.65 mL |
| 7.0 kg | 105 mg | 0.70 mL |
| 7.5 kg | 112.5 mg | 0.75 mL |
| 8.0 kg | 120 mg | 0.80 mL |
⏱️ Interval
āĻĒ্āϰাāĻĨāĻŽিāĻ dose → 48 āĻāĻŖ্āĻা → āĻĒ্āϰā§োāĻāύ āĻšāϞে repeat। Product information-āĻ āĻāĻ 48-hour repeat regimen āĻĻেāĻā§া āĻāĻে। (Medicines EU)
āϤāĻŦে āĻāĻāĻি āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ āĻĒাāϰ্āĻĨāĻ্āϝ āĻāĻে: āĻিāĻু Invemox product information 5–7 āĻĻিāύেāϰ āĻŦেāĻļি treatment āύা āĻŦাā§াāϤে āĻāĻŦং 48 āĻāĻŖ্āĻাā§ improvement āύা āĻšāϞে treatment reconsider āĻāϰāϤে āĻŦāϞে; āĻ āύ্āϝ official 150-mg/mL amoxicillin LA label-āĻ dogs/cats-āĻāϰ āĻāύ্āϝ āĻāĻāĻি 48-hour repeat-āĻ āĻāϞ্āϞেāĻ āĻāĻে। āϤাāĻ āĻāĻĒāύাāϰ āĻŦাংāϞাāĻĻেāĻļে āĻŦিāĻ্āϰি āĻšāĻā§া Invemox 15% LA vial-āĻāϰ insert/label āĻāĻŦং veterinarian-āĻāϰ āύিāϰ্āĻĻেāĻļāύাāĻ āĻূā§াāύ্āϤ āĻšāĻā§া āĻāĻিāϤ। (Farm Chemie)
đ Administration
IM āĻ āĻĨāĻŦা SC — product-specific instructions āĻ āύুāϝাā§ী। (Medicines EU)
IV āύā§।
Suspension āĻšāĻā§াā§ āĻাāϞোāĻাāĻŦে shake āĻāϰāϤে āĻšā§। (Medicines EU)
āĻোāĻ dose, āϝেāĻŽāύ 0.05–0.30 mL, āĻুāĻŦ āύিāϰ্āĻুāϞāĻাāĻŦে āĻŽাāĻĒা āĻāϰুāϰি; graduated 1-mL syringe āĻ āĻ্āώেāϤ্āϰে āĻŦেāĻļি āĻāĻĒāϝোāĻী। (Abbey Labs)
Penicillin/β-lactam allergy āĻĨাāĻāϞে āĻŦ্āϝāĻŦāĻšাāϰ āĻāϰা āĻāĻিāϤ āύā§। (Farm Chemie)
⚠️ āĻŦিāĻļেāώ āĻāϰে pneumonia-āĻāϰ āĻ্āώেāϤ্āϰে
āĻāĻ dose chart “āϝে āĻোāύো āύিāĻāĻŽোāύিā§াāϰ āĻিāĻিā§āϏা” āύিāĻļ্āĻিāϤ āĻāϰে āύা। Amoxicillin āĻেāĻŦāϞ susceptible bacterial infection-āĻ āĻাāĻ āĻāϰāĻŦে। āĻাāĻāϰাāϞ infection, aspiration pneumonia, resistant bacteria āĻŦা Mycoplasma-āĻাāϤীā§ organism āĻšāϞে āĻ āύ্āϝ approach āĻĒ্āϰā§োāĻāύ āĻšāϤে āĻĒাāϰে।
āĻļ্āĻŦাāϏāĻāώ্āĻ, āĻŽুāĻ/āĻিāĻš্āĻŦা āύীāϞāĻে āĻšāĻā§া, āĻুāĻŦ āĻĻ্āϰুāϤ āĻļ্āĻŦাāϏ, collapse, severe dehydration āĻŦা āĻাāĻā§া āĻŦāύ্āϧ āĻāϰে āĻĻেāĻā§া āĻĨাāĻāϞে 48 āĻāĻŖ্āĻা āĻ āĻĒেāĻ্āώা āύা āĻāϰে āĻāϰুāϰি veterinary treatment āĻĒ্āϰā§োāĻāύ।
āĻāϰ āĻāĻāĻি āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ āĻāĻĨা: āĻŦিā§াāϞ āĻŦা āĻুāĻুāϰেāϰ UTI, pneumonia, skin infection, abscess—āϏāĻŦāĻুāϞোāϰ āĻāύ্āϝ āĻāĻāĻ antibiotic āĻ āĻāĻāĻ duration āϧāϰে āύেāĻā§া āĻ িāĻ āύā§। āϰোāĻāĻেāĻĻে treatment āĻāϞাāĻĻা āĻšāϤে āĻĒাāϰে।
āĻ āĻŦāĻļ্āϝāĻ। āĻāĻাāύে Invemox 15% LA-āĻāϰ 15 mg/kg dose-āĻে āϰোāĻāĻিāϤ্āϤিāĻāĻাāĻŦে āĻāϞাāĻĻা āĻāϰে “culture āĻāĻāύ āύেāĻŦেāύ”—āĻāĻ āĻĻুāĻো āĻŦিāώ⧠āĻāĻāϏāĻ্āĻে āĻĻেāĻাāϞাāĻŽ। āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ āĻšāϞো, dose āĻāĻāĻ āĻšāϞেāĻ āϰোāĻāĻেāĻĻে culture-āĻāϰ āĻĒ্āϰā§োāĻāύীā§āϤা āĻ sample āύেāĻā§াāϰ āĻাā§āĻা āĻāϞাāĻĻা।
| āϰোāĻ | Invemox 15% LA-āĻāϰ āĻšিāϏাāĻŦ* | Culture/AST āĻāĻāύ āĻāϰāĻŦেāύ? | Sample āĻীāĻাāĻŦে | āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ āĻŦিāώ⧠|
|---|---|---|---|---|
| đĢ Pneumonia | 15 mg/kg = 0.1 mL/kg | āϏāĻŽ্āĻāĻŦ āĻšāϞে āĻĒ্āϰāĻĨāĻŽ antibiotic-āĻāϰ āĻāĻে | āĻāĻীāϰ respiratory sample/airway sample—āĻেāĻেāϰিāύাāϰি clinic-āĻ | āĻĒ্āϰাāĻŖী stable āĻšāϞে culture āĻāĻে; āĻিāύ্āϤু severe pneumonia/sepsis āĻšāϞে culture-āĻāϰ āĻāύ্āϝ treatment āĻĻেāϰি āĻāϰা āĻāĻিāϤ āύā§। (PubMed Central (PMC)) |
| đ Skin infection / pyoderma | 15 mg/kg = 0.1 mL/kg | systemic antibiotic āĻĻেāĻā§াāϰ āĻĒāϰিāĻāϞ্āĻĒāύা āĻĨাāĻāϞে culture/AST āĻŦিāĻŦেāĻāύা āĻāϰুāύ; recurrent/resistant āĻšāϞে āĻ āĻŦāĻļ্āϝāĻ āĻŦেāĻļি āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ | pustule/pus/lesion-āĻāϰ āĻāĻীāϰ material, sterile swab/aspirate | Cytology + culture āϏāĻŦāĻেā§ে āĻাāϰ্āϝāĻāϰ; surface contamination āĻā§াāύো āĻāϰুāϰি। (PubMed Central (PMC)) |
| đŊ UTI | 15 mg/kg = 0.1 mL/kg | āϏāĻŽ্āĻāĻŦ āĻšāϞে āĻĒ্āϰāĻĨāĻŽ dose-āĻāϰ āĻāĻে | Cystocentesis urine āϏāĻŦāĻেā§ে āĻাāϞো | Complicated/recurrent UTI-āϤে culture āĻ āϤ্āϝāύ্āϤ āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ; pyelonephritis āϏāύ্āĻĻেāĻš āĻšāϞে culture āĻāϰা āĻāĻিāϤ। (PubMed Central (PMC)) |
| 𩹠āĻ্āώāϤ + āĻĒুঁāĻ/abscess | 15 mg/kg = 0.1 mL/kg | antibiotic āĻļুāϰু āĻāϰাāϰ āĻāĻে, āĻŦিāĻļেāώ āĻāϰে deep/recurrent/non-healing lesion āĻšāϞে | āĻāĻীāϰ pus/aspirate āĻŦা lesion-āĻāϰ representative material | āĻļুāϧু āĻāĻĒāϰিāĻাāĻেāϰ swab āĻāϰāϞে contaminant āĻĒাāĻā§া āϝেāϤে āĻĒাāϰে; drainage/source control āĻ āύেāĻ āϏāĻŽā§ antibiotic-āĻāϰ āĻŽāϤোāĻ āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ। (PubMed Central (PMC)) |
* 0.1 mL/kg āĻļুāϧুāĻŽাāϤ্āϰ āϤāĻāύāĻ āĻĒ্āϰāϝোāĻ্āϝ āϝāĻāύ āĻāĻĒāύাāϰ Invemox 15% LA vial-āĻ amoxicillin concentration 150 mg/mL āĻāĻŦং āĻāĻĒāύাāϰ āĻŦ্āϝāĻŦāĻšৃāϤ product label 15 mg/kg dose āύিāϰ্āĻĻেāĻļ āĻāϰে। Product-specific label/āĻেāĻেāϰিāύাāϰিāϰ āύিāϰ্āĻĻেāĻļāύা āĻ āĻ্āϰাāϧিāĻাāϰ āĻĒাāĻŦে।
đ§Ē Culture-āĻāϰ timing — āϏāĻšāĻ āύিā§āĻŽ
āϏāĻŦāĻেā§ে āĻাāϞো:
Sample → Culture/AST → āϤাāϰāĻĒāϰ antibiotic, āϝāĻĻি āĻĒ্āϰাāĻŖী clinically stable āĻĨাāĻে।
āĻিāύ্āϤু pneumonia/sepsis-āĻ:
Culture sample āύেāĻā§া āϏāĻŽ্āĻāĻŦ āĻšāϞে āĻāĻে āύিāύ, āĻিāύ্āϤু culture report āĻāϏা āĻĒāϰ্āϝāύ্āϤ āĻুāϰুāϤāϰ āĻ
āϏুāϏ্āĻĨ āĻĒ্āϰাāĻŖীāĻে antibiotic āĻাā§া āϰেāĻে āĻĻেāĻā§া āĻāĻিāϤ āύā§। Respiratory guidelines empirical treatment āĻļুāϰু āĻāϰাāϰ āĻĒাāĻļাāĻĒাāĻļি culture/AST āĻĻিā§ে āĻĒāϰে treatment adjust āĻāϰাāϰ āĻāĻĨা āĻŦāϞে। (PubMed Central (PMC))
đŊ UTI-āĻāϰ āĻ্āώেāϤ্āϰে āĻāĻāĻু āĻāϞাāĻĻা
UTI āϏāύ্āĻĻেāĻš āĻšāϞে cystocentesis urine sample culture-āĻāϰ āĻāύ্āϝ preferred। Free-catch urine contamination-āĻāϰ āĻাāϰāĻŖে diagnostic culture āĻšিāϏেāĻŦে āĻāĻŽ āύিāϰ্āĻāϰāϝোāĻ্āϝ। (PubMed Central (PMC))
Complicated/recurrent UTI-āϤে culture result āĻ āύুāϝাā§ী antibiotic āĻĒāϰিāĻŦāϰ্āϤāύ āĻāϰা āĻāĻিāϤ। Pyelonephritis āϏāύ্āĻĻেāĻš āĻšāϞে culture āĻŦিāĻļেāώāĻাāĻŦে āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ। (PubMed Central (PMC))
đ Skin infection / āĻ্āώāϤ-āĻĒুঁāĻ
āĻļুāϧু “āĻĒুঁāĻেāϰ āĻāĻĒāϰ cotton swab āĻāώে” culture āĻāϰাāύো āĻāĻĻāϰ্āĻļ āύā§। pustule-āĻāϰ āĻিāϤāϰেāϰ material, āĻāĻীāϰ pus āĻŦা aspirate āĻŦেāĻļি representative। Skin infection-āĻ cytology-āĻāϰ āϏāĻ্āĻে bacterial culture/susceptibility testing āĻāϰāϞে antibiotic selection āĻ āύেāĻ āĻŦেāĻļি āύিāϰ্āĻāϰāϝোāĻ্āϝ āĻšā§। (PubMed Central (PMC))
⚠️ āĻāĻāĻি āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ āϏংāĻļোāϧāύ
āĻāĻ āĻাāϰāĻি āϰোāĻেāϰ āĻāύ্āϝ 15 mg/kg dose āĻāĻāĻ āĻŦāϞে treatment duration-āĻ āĻāĻāĻ āĻšāĻŦে—āĻāĻŽāύ āύā§। āĻŦিāĻļেāώ āĻāϰে pneumonia, deep abscess āĻāĻŦং complicated UTI-āϤে āϰোāĻেāϰ severity āĻ culture result āĻ āύুāϝাā§ী treatment āĻĒāϰিāĻŦāϰ্āϤিāϤ āĻšāϤে āĻĒাāϰে।
āĻāϰ 48 āĻāĻŖ্āĻাāϰ āĻŽāϧ্āϝে pneumonia/āĻ্āĻŦāϰ/āĻĒুঁāĻেāϰ infection-āĻ clinical improvement āύা āĻšāϞে āĻļুāϧু Invemox-āĻāϰ dose āĻŦাā§াāĻŦেāύ āĻŦা āĻŦাāϰāĻŦাāϰ āĻĻেāĻŦেāύ āύা—diagnosis, culture/AST āĻāĻŦং antibiotic choice āĻĒুāύāϰ্āĻŽূāϞ্āϝাā§āύ āĻāϰা āĻāĻিāϤ।
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
>> COMBICILLIN-LA āĻāϰ āϏāĻŽ্āĻĒāϰ্āĻে āĻŦিāϏ্āϤাāϰিāϤ :
COMBICILLIN-LA āĻāĻāĻি āĻেāĻেāϰিāύাāϰি āĻ ্āϝাāύ্āĻিāĻŦাāϝ়োāĻিāĻ āĻāύāĻেāĻāĻļāύ। āĻŦাংāϞাāĻĻেāĻļে DGDA-āϰ āύāĻĨিāϤেāĻ Combicillin-LA Inj. (Vet)-āĻāϰ āĻāĻĒাāĻĻাāύ āĻšিāϏেāĻŦে Procaine Penicillin G, Benzathine Penicillin G āĻāĻŦং Dihydrostreptomycin Sulphate āĻāϞ্āϞেāĻ āĻāĻে। (Oracle Cloud)
đ COMBICILLIN-LA āĻী āĻĨাāĻে?
Komipharm-āĻāϰ āĻ āĻĢিāϏিāϝ়াāϞ āϤāĻĨ্āϝ āĻ āύুāϝাāϝ়ী āĻāĻি āĻŽূāϞāϤ Penicillin + Dihydrostreptomycin-āĻিāϤ্āϤিāĻ āĻĻীāϰ্āĻ-āĻাāϰ্āϝāĻাāϰী (LA = Long Acting) āĻ ্āϝাāύ্āĻিāĻŦাāϝ়োāĻিāĻ। āϤাāĻĻেāϰ āύিāϰ্āĻĻেāĻļāύাāϝ়:
Procaine Penicillin G — 150,000 IU/ml
Benzathine Penicillin G — 100,000 IU/ml
Dihydrostreptomycin — 200 mg/ml
āĻŦাংāϞাāĻĻেāĻļেāϰ DGDA āύāĻĨিāϤেāĻ āĻāĻāĻ āĻāĻŽ্āĻŦিāύেāĻļāύ āĻāϞ্āϞেāĻ āĻāϰা āĻšāϝ়েāĻে। (Komipharm International Co., Ltd.)
đĻ āĻোāύ āϰোāĻে āĻŦ্āϝāĻŦāĻšাāϰ āĻāϰা āĻšāϝ়?
āĻāĻি āĻŦ্āϝাāĻāĻেāϰিāϝ়াāĻāύিāϤ āϏংāĻ্āϰāĻŽāĻŖে āĻŦ্āϝāĻŦāĻšাāϰ āĻāϰা āĻšāϝ়—āĻাāĻāϰাāϏ, āĻāϤ্āϰাāĻ āĻŦা āĻৃāĻŽিāϰ āĻāώুāϧ āύāϝ়।
āĻĒ্āϰāϏ্āϤুāϤāĻাāϰāĻেāϰ āϤāĻĨ্āϝ āĻ āύুāϝাāϝ়ী āĻāĻŦাāĻĻিāĻĒāĻļুāϤে āĻāĻি āĻŦ্āϝāĻŦāĻšাāϰ āĻāϰা āĻšāϝ় āϝেāĻŽāύ:
āĻŦ্āϝাāĻāĻেāϰিāϝ়াāϞ pneumonia
Mastitis
Uteritis
āĻŦ্āϝাāĻāĻেāϰিāϝ়াāϞ diarrhea
Pasteurella infection
E. coli infection
Salmonella infection
Staphylococcus aureus–āĻāύিāϤ āϏংāĻ্āϰāĻŽāĻŖ
āĻļূāĻāϰেāϰ āĻ্āώেāϤ্āϰে āĻāϰāĻ āĻিāĻু āύিāϰ্āĻĻিāώ্āĻ bacterial infection-āĻ āĻŦ্āϝāĻŦāĻšাāϰ āĻāϰা āĻšāϝ়। (Komipharm International Co., Ltd.)
đ āĻুāĻুāϰ/đ āĻŦিāĻĄ়াāϞেāϰ āĻāύ্āϝ?
āĻāĻাāύে āĻŦিāĻļেāώ āϏāϤāϰ্āĻāϤা āĻĻāϰāĻাāϰ। āĻāĻāĻ āϧāϰāύেāϰ penicillin–dihydrostreptomycin LA āĻĒāĻŖ্āϝ āĻিāĻু āĻĻেāĻļে āĻুāĻুāϰ āĻ āĻŦিāĻĄ়াāϞāϏāĻš āĻŦিāĻিāύ্āύ āĻĒ্āϰাāĻŖীāϰ āĻāύ্āϝ āĻ āύুāĻŽোāĻĻিāϤ āĻšāϞেāĻ COMBICILLIN-LA-āĻāϰ āύিāϰ্āĻĻিāώ্āĻ āĻŦাংāϞাāĻĻেāĻļি āĻĒ্āϝাāĻেāĻেāϰ label/approved species āĻ āύুāϏāϰāĻŖ āĻāϰা āĻāϰুāϰি। āĻāĻāĻ āύাāĻŽেāϰ āĻĒāĻŖ্āϝেāϰ formulation āĻ āĻ āύুāĻŽোāĻĻিāϤ āĻĒ্āϰাāĻŖী āĻĻেāĻļāĻেāĻĻে āĻāϞাāĻĻা āĻšāϤে āĻĒাāϰে। (Kela)
đ āĻĒ্āϰāϏ্āϤুāϤāĻাāϰāĻেāϰ āĻĻেāĻāϝ়া āĻĄোāĻ
Komipharm-āĻāϰ COMBICILLIN-LA āϤāĻĨ্āϝ āĻ āύুāϝাāϝ়ী:
5 mL / 100 kg body weight, IM
āĻāĻŦং 48 āĻāĻŖ্āĻা āĻĒāϰ āĻĻ্āĻŦিāϤীāϝ় injection āĻĻেāĻāϝ়াāϰ āύিāϰ্āĻĻেāĻļāύা āϰāϝ়েāĻে। āĻāĻ injection site-āĻ 5 mL-āĻāϰ āĻŦেāĻļি āύা āĻĻেāĻāϝ়াāϰ āĻāĻĨা āĻŦāϞা āĻšāϝ়েāĻে। (Komipharm International Co., Ltd.)
āϤāĻŦে āĻুāĻুāϰ/āĻŦিāĻĄ়াāϞ āĻŦা āĻ āύ্āϝ āĻোāĻ āĻĒ্āϰাāĻŖীāϰ āĻ্āώেāϤ্āϰে āĻāĻ cattle dose āϏāϰাāϏāϰি āĻĒ্āϰāϝ়োāĻ āĻāϰা āϝাāĻŦে āύা। āĻāĻāύ, species, āϰোāĻ āĻāĻŦং formulation āĻ āύুāϝাāϝ়ী veterinary dose āύিāϰ্āϧাāϰāĻŖ āĻāϰāϤে āĻšāϝ়।
⚠️ āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ āϏāϤāϰ্āĻāϤা
āĻāĻি āĻļāĻ্āϤিāĻļাāϞী āĻ ্āϝাāύ্āĻিāĻŦাāϝ়োāĻিāĻ, āϤাāĻ āĻļুāϧু āĻ্āĻŦāϰ āĻŦা āϝেāĻোāύো āĻ āϏুāϏ্āĻĨāϤাāϝ় āĻŦ্āϝāĻŦāĻšাāϰ āĻāϰা āĻāĻিāϤ āύāϝ়।
āĻŦিāĻļেāώ āĻāϰে:
Penicillin allergy āĻĨাāĻāϞে āĻŦিāĻĒāĻ্āĻāύāĻ reaction āĻšāϤে āĻĒাāϰে।
Dihydrostreptomycin āĻāĻāĻি aminoglycoside-āĻাāϤীāϝ় antibiotic; āĻুāϞ āĻŦ্āϝāĻŦāĻšাāϰ āĻāϰāϞে āĻিāĻĄāύি āĻ āĻļ্āϰāĻŦāĻŖ/āĻাāϰāϏাāĻŽ্āϝ-āϏংāĻ্āϰাāύ্āϤ toxicity āĻšāϤে āĻĒাāϰে।
āĻāĻāĻ āϏāĻ্āĻে āĻ āύ্āϝ aminoglycoside āĻŦা āĻিāĻু nephrotoxic drug āĻŦ্āϝāĻŦāĻšাāϰে āϏāϤāϰ্āĻāϤা āĻĻāϰāĻাāϰ।
āĻāϰ্āĻāĻŦāϤী āĻĒ্āϰাāĻŖী, āĻিāĻĄāύি āϰোāĻী āĻāĻŦং āĻুāĻŦ āĻĻুāϰ্āĻŦāϞ āĻĒ্āϰাāĻŖীāϰ āĻ্āώেāϤ্āϰে veterinary supervision āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ।
āĻাāĻĻ্āϝ-āĻā§āĻĒাāĻĻāύāĻাāϰী āĻĒ্āϰাāĻŖীāϤে meat/milk withdrawal period āĻ āĻŦāĻļ্āϝāĻ label āĻ āύুāϝাāϝ়ী āĻŽাāύāϤে āĻšāĻŦে।
āĻ āĻĒ্āϰāϝ়োāĻāύীāϝ় antibiotic āĻŦ্āϝāĻŦāĻšাāϰ āĻāϰāϞে antimicrobial resistance āϤৈāϰি āĻšāϤে āĻĒাāϰে।
❗ āĻāĻāĻি āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ āĻŦিāώāϝ়
āĻāĻĒāύি āϝāĻĻি āĻুāĻুāϰ āĻŦা āĻŦিāĻĄ়াāϞেāϰ āĻāύ্āϝ COMBICILLIN-LA āϏāĻŽ্āĻĒāϰ্āĻে āĻাāύāϤে āĻাāύ—āĻŦিāĻļেāώ āĻāϰে āĻĒাāϝ়āĻাāύাāϝ় āĻাāϞ/āĻļāϏাāϰ āĻŦীāĻেāϰ āĻŽāϤো āĻৃāĻŽিāϰ āĻ ংāĻļ āĻĻেāĻা āϝাāĻāϝ়া, āĻ্āώāϤ, āĻĒুঁāĻ, āĻ্āĻŦāϰ āĻŦা āĻ āύ্āϝ āĻোāύো āύিāϰ্āĻĻিāώ্āĻ āϏāĻŽāϏ্āϝাāϰ āĻāύ্āϝ—āϤাāĻšāϞে COMBICILLIN-LA āϏাāϧাāϰāĻŖāϤ āĻৃāĻŽিāύাāĻļāĻ āύāϝ়। āĻāĻি bacterial infection-āĻāϰ antibiotic।
đ āĻāĻ COMBICILLIN-LA-āϤে āĻী āĻāĻে?
āĻĒ্āϰāϤি 1 mL-āĻ:
| āĻāĻĒাāĻĻাāύ | āĻĒāϰিāĻŽাāĻŖ |
|---|---|
| Procaine Penicillin G | 150,000 IU |
| Benzathine Penicillin G | 100,000 IU |
| Dihydrostreptomycin | 200 mg |
āĻ āϰ্āĻĨাā§ āĻāĻি āĻĻুāĻ āϧāϰāύেāϰ Penicillin + Dihydrostreptomycin-āĻāϰ āĻĻীāϰ্āĻ-āĻাāϰ্āϝāĻাāϰী āĻ ্āϝাāύ্āĻিāĻŦাāϝ়োāĻিāĻ। (Komipharm International Co., Ltd.)
đĻ āĻী āϧāϰāύেāϰ āϏংāĻ্āϰāĻŽāĻŖে āĻŦ্āϝāĻŦāĻšাāϰ āĻšāϝ়?
āĻāĻি āĻŦ্āϝাāĻāĻেāϰিāϝ়াāϞ infection-āĻāϰ āĻিāĻিā§āϏাāϰ āĻāύ্āϝ। āĻĒ্āϰāϏ্āϤুāϤāĻাāϰāĻেāϰ āϤāĻĨ্āϝ āĻ āύুāϝাāϝ়ী āϏংāĻŦেāĻĻāύāĻļীāϞ āĻŦ্āϝাāĻāĻেāϰিāϝ়াāϰ āĻŽāϧ্āϝে āϰāϝ়েāĻে Pasteurella multocida, E. coli, Salmonella typhimurium āĻāĻŦং Staphylococcus aureus। āĻāĻŦাāĻĻিāĻĒāĻļুāϤে pneumonia, mastitis, uteritis āĻ bacterial diarrhea-āĻāϰ āĻŽāϤো āϏংāĻ্āϰāĻŽāĻŖে āĻŦ্āϝāĻŦāĻšাāϰ āĻāϰা āĻšāϝ়। (Komipharm International Co., Ltd.)
āĻāĻি āĻৃāĻŽিāύাāĻļāĻ āύāϝ়। āϤাāĻ āĻĒাāϝ়āĻাāύাāϝ় āĻĢিāϤা āĻৃāĻŽি/āĻৃāĻŽিāϰ āĻ ংāĻļ āĻĻেāĻা āĻেāϞে COMBICILLIN-LA āĻĻিāϝ়ে āϏেāĻ āĻৃāĻŽি āĻŽাāϰা āϝাāĻŦে āύা।
đđ āĻুāĻুāϰ āĻ āĻŦিāĻĄ়াāϞেāϰ āĻŦ্āϝাāĻĒাāϰে āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ āϤāĻĨ্āϝ
āĻāĻাāύে āĻāĻāĻি āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ āĻŦিāώāϝ় āĻāĻে: Komipharm-āĻāϰ Korean product information-āĻ āĻুāĻুāϰ āĻ āĻŦিāĻĄ়াāϞেāϰ āĻāύ্āϝ āĻāϞাāĻĻা dosing āĻāϞ্āϞেāĻ āĻāĻে—āĻুāĻুāϰ/āĻŦিāĻĄ়াāϞেāϰ āĻ্āώেāϤ্āϰে 0.5–1 mL/animal, 2–3 āĻĻিāύ āĻĒāϰāĻĒāϰ IM āĻĻেāĻāϝ়াāϰ āĻāĻĨা āĻŦāϞা āĻšāϝ়েāĻে। āĻāĻāĻ āĻĒৃāώ্āĻ াāϝ় penicillin āĻŦা streptomycin hypersensitivity āĻĨাāĻāϞে āĻŦ্āϝāĻŦāĻšাāϰ āύা āĻāϰāϤে āĻŦāϞা āĻšāϝ়েāĻে āĻāĻŦং veterinarian-āĻāϰ āύিāϰ্āĻĻেāĻļ āĻ āύুāϏāϰāĻŖেāϰ āĻāĻĨা āĻŦāϞা āĻšāϝ়েāĻে। (Komipharm International Co., Ltd.)
āϤāĻŦে āĻĒ্āϰāϏ্āϤুāϤāĻাāϰāĻেāϰ āĻŦāϰ্āϤāĻŽাāύ English product page-āĻ cattle āĻ pig-āĻāϰ indications/dose āĻāϞাāĻĻাāĻাāĻŦে āĻĻেāĻāϝ়া āĻšāϝ়েāĻে (5 mL/100 kg IM, 48 āĻāĻŖ্āĻা interval)। āϤাāĻ āĻāĻĒāύাāϰ āĻšাāϤে āĻĨাāĻা āĻŦাংāϞাāĻĻেāĻļেāϰ āĻĒ্āϝাāĻেāĻেāϰ leaflet/approved species āĻ local label āĻĻেāĻে āĻুāĻুāϰ-āĻŦিāĻĄ়াāϞেāϰ dose āύিāϰ্āϧাāϰāĻŖ āĻāϰা āĻāĻিāϤ; cattle dose āĻোāĻ āĻĒ্āϰাāĻŖীāϤে āϏāϰাāϏāϰি āĻĒ্āϰāϝ়োāĻ āĻāϰা āϝাāĻŦে āύা। (Komipharm International Co., Ltd.)
⚠️ āĻŦিāĻļেāώ āϏāϤāϰ্āĻāϤা
Penicillin āĻŦা streptomycin-āĻ allergy āĻĨাāĻāϞে āĻŦ্āϝāĻŦāĻšাāϰ āĻāϰা āĻāĻিāϤ āύāϝ়। (Komipharm International Co., Ltd.)
āĻāĻি IM (intramuscular) injection āĻšিāϏেāĻŦে āĻĻেāĻāϝ়াāϰ āĻāύ্āϝ।
āĻĒ্āϰāϏ্āϤুāϤāĻাāϰāĻেāϰ āĻŦāϰ্āϤāĻŽাāύ English āύিāϰ্āĻĻেāĻļāύাāϝ় āĻāĻ injection site-āĻ 5 mL-āĻāϰ āĻŦেāĻļি āύা āĻĻেāĻāϝ়াāϰ āĻāĻĨা āĻāĻে। (Komipharm International Co., Ltd.)
āĻ āĻĒ্āϰāϝ়োāĻāύীāϝ়āĻাāĻŦে antibiotic āĻŦ্āϝāĻŦāĻšাāϰ āĻāϰāϞে antibiotic resistance-āĻāϰ āĻুঁāĻি āĻŦাāĻĄ়ে।
āĻুāϰুāϤāϰ allergic reaction āĻšāϞে āĻĻ্āϰুāϤ veterinary treatment āĻĻāϰāĻাāϰ।
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
Invemox 15% LA Inj āĻāϰ āϏāĻŽ্āĻĒāϰ্āĻে āĻŦিāϏ্āϤাāϰিāϤ :
Invemox 15% LA Inj. āĻāĻāĻি long-acting veterinary antibiotic injection, āϝাāϰ āĻŽূāϞ active ingredient āĻšāϞো Amoxicillin (as trihydrate) 150 mg/mL। āĻŦাংāϞাāĻĻেāĻļে āĻāĻি ACI-āĻāϰ veterinary drug āϤাāϞিāĻাāϝ় 10, 50 āĻ 100 mL vial āĻšিāϏেāĻŦে āĻāϞ্āϞেāĻ āĻāĻে। (DG Drug Administration)
đ Invemox 15% LA-āĻāϰ āĻŽূāϞ āϤāĻĨ্āϝ
| āĻŦিāώ⧠| āϤāĻĨ্āϝ |
|---|---|
| Generic | Amoxicillin trihydrate |
| Strength | 150 mg/mL (15%) |
| āϧāϰāύ | Long-acting antibiotic |
| Route | IM / SC |
| āĻাāĻ | āϏংāĻŦেāĻĻāύāĻļীāϞ āĻŦ্āϝাāĻāĻেāϰিāϝ়া āĻĻāĻŽāύ/āύিāϰ্āĻŽূāϞ |
| āĻŦাংāϞাāĻĻেāĻļে | ACI-āĻāϰ veterinary product āĻšিāϏেāĻŦে āϤাāϞিāĻাāĻুāĻ্āϤ |
| Target animals | Cattle, sheep, pig; āĻিāĻু āĻ āύুāĻŽোāĻĻিāϤ formulation-āĻ dog & cat-āĻ |
āĻāĻāĻি āϏāϰāĻাāϰি veterinary product āϤāĻĨ্āϝāϏূāϤ্āϰে Invemox 15% LA-āĻে cattle, sheep, pigs, dogs āĻ cats-āĻāϰ āĻāύ্āϝ āύিāĻŦāύ্āϧিāϤ āĻāĻŦং 150 mg/mL amoxicillin āĻšিāϏেāĻŦে āĻāϞ্āϞেāĻ āĻāϰা āĻšāϝ়েāĻে। (Medicines Europe)
đĻ āĻোāύ āϰোāĻে āĻŦ্āϝāĻŦāĻšাāϰ āĻāϰা āĻšāϝ়?
Amoxicillin-sensitive bacterial infection-āĻāϰ āĻ্āώেāϤ্āϰে āĻāĻি āĻŦ্āϝāĻŦāĻšাāϰ āĻāϰা āĻšāϝ়। āĻāĻĻাāĻšāϰāĻŖ:
Respiratory infection — pneumonia, bronchitis āĻāϤ্āϝাāĻĻি
Skin āĻ soft-tissue infection
Wound infection
Abscess
Urinary/genitourinary bacterial infection
Uterine/reproductive bacterial infection
Mastitis
āĻিāĻু gastrointestinal bacterial infection
āύিāϰ্āĻĻিāώ্āĻ āϰোāĻে āĻŦ্āϝāĻŦāĻšাāϰ āĻāϰাāϰ āĻāĻে infection-āĻি bacterial āĻāĻŦং amoxicillin-sensitive āĻšāĻāϝ়া āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ। (Medicines Europe)
đ āĻুāĻুāϰেāϰ āĻ্āώেāϤ্āϰে
āĻিāĻু official/registered product information-āĻ āĻুāĻুāϰেāϰ āĻāύ্āϝ 1 mL/10 kg body weight, āĻ āϰ্āĻĨাā§ 15 mg/kg amoxicillin, IM/SC route-āĻ āĻĻেāĻāϝ়াāϰ āϤāĻĨ্āϝ āϰāϝ়েāĻে āĻāĻŦং āĻĒ্āϰāϝ়োāĻāύ āĻšāϞে 48 āĻāĻŖ্āĻা āĻĒāϰে repeat āĻāϰাāϰ āĻāĻĨা āĻŦāϞা āĻšāϝ়েāĻে। (Nutrex Bolivia)
āĻŦাংāϞাāĻĻেāĻļেāϰ veterinary drug references-āĻāĻ Invemox 15% LA: 1 mL/10 kg, SC/IM, 48-hour interval āĻāϞ্āϞেāĻ āϰāϝ়েāĻে। (Scribd)
āϤāĻŦে āĻāĻি āĻĒ্āϰেāϏāĻ্āϰিāĻĒāĻļāύ āĻšিāϏেāĻŦে āϧāϰে āύিāϝ়ে āύিāĻে āĻĨেāĻে injection āĻĻেāĻāϝ়া āĻ িāĻ āύāϝ়। āĻŦিāĻļেāώ āĻāϰে puppy/kitten, āĻুāĻŦ āĻĻুāϰ্āĻŦāϞ āĻĒ্āϰাāĻŖী, kidney disease āĻŦা dehydration āĻĨাāĻāϞে veterinarian-āĻāϰ āĻŽূāϞ্āϝাāϝ়āύ āĻĻāϰāĻাāϰ।
đ āĻŦিāĻĄ়াāϞেāϰ āĻ্āώেāϤ্āϰে
āĻিāĻু āύিāĻŦāύ্āϧিāϤ Invemox 15% LA formulation-āĻ āĻŦিāĻĄ়াāϞāĻ target species āĻšিāϏেāĻŦে āϰāϝ়েāĻে। (Medicines Europe)
āϤāĻŦে āĻŦিāĻĄ়াāϞেāϰ āĻāύ্āϝ 0.5 mL/5 kg-āĻāϰ āĻŽāϤো dose āĻিāĻু product information-āĻ āĻĻেāĻāϝ়া āĻšāϝ়েāĻে—āĻāĻি āĻāĻĒāύাāϰ āĻšাāϤে āĻĨাāĻা āύিāϰ্āĻĻিāώ্āĻ vial-āĻāϰ leaflet-āĻāϰ āϏāĻ্āĻে āĻŽিāϞিāϝ়ে āύিāϤে āĻšāĻŦে। (torsineen)
⚠️ āϏāĻŦāĻেāϝ়ে āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ: āĻāĻি āĻৃāĻŽিāϰ āĻāώুāϧ āύāϝ়
āĻāĻĒāύি āĻāĻেāϰ āĻāĻĨাāϝ় āĻĒাāϝ়āĻাāύাāϝ় āĻাāϞ/āĻļāϏাāϰ āĻŦীāĻেāϰ āĻŽāϤো āĻোāĻ āĻোāĻ āĻুāĻāϰা āĻĻেāĻাāϰ āĻāĻĨা āĻŦāϞেāĻিāϞেāύ। āϏেāĻুāϞো āϝāĻĻি tapeworm segment āĻšāϝ়, āϤাāĻšāϞে:
Invemox 15% LA → ❌ āĻৃāĻŽি āĻŽাāϰāĻŦে āύা
Combicillin-LA → ❌ āĻৃāĻŽি āĻŽাāϰāĻŦে āύা
āĻĻুāĻিāĻ antibiotic; dewormer āύāϝ়।
Tapeworm-āĻāϰ āĻ্āώেāϤ্āϰে āϏাāϧাāϰāĻŖāϤ praziquantel-āĻাāϤীāϝ় anthelmintic āĻĒ্āϰāϝ়োāĻāύ āĻšāϝ় āĻāĻŦং flea control-āĻ āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ āĻšāϤে āĻĒাāϰে।
Invemox āĻŦāύাāĻŽ āĻāĻĒāύাāϰ āĻāĻেāϰ COMBICILLIN-LA
| Invemox 15% LA | COMBICILLIN-LA | |
|---|---|---|
| āĻĒ্āϰāϧাāύ antibiotic | Amoxicillin | Penicillin + Dihydrostreptomycin |
| Strength | 150 mg/mL | 150,000 IU + 100,000 IU + 200 mg/mL |
| Long acting | ✅ | ✅ |
| Bacterial infection | ✅ | ✅ |
| āĻৃāĻŽি āĻŽাāϰে | ❌ | ❌ |
| āĻāĻāĻ āϏāĻ্āĻে āĻŦ্āϝāĻŦāĻšাāϰ | āϏাāϧাāϰāĻŖāϤ āĻĒ্āϰāϝ়োāĻāύ āύেāĻ | āϏাāϧাāϰāĻŖāϤ āĻĒ্āϰāϝ়োāĻāύ āύেāĻ |
āĻāĻāĻ infection-āĻāϰ āĻāύ্āϝ Invemox āĻāĻŦং Combicillin-LA āĻāĻāϏāĻ্āĻে āĻĻেāĻāϝ়া āĻāĻিāϤ āĻি āύা—āĻļুāϧু āύাāĻŽ āĻĻেāĻে āϏিāĻĻ্āϧাāύ্āϤ āύেāĻāϝ়া āĻāĻিāϤ āύāϝ়। āĻāϤে āĻ āĻĒ্āϰāϝ়োāĻāύীāϝ় antibiotic exposure āĻāĻŦং adverse-effect/resistance-āĻāϰ āĻুঁāĻি āĻŦাāĻĄ়āϤে āĻĒাāϰে।
āĻāĻ āĻāĻĨাā§ “āĻোāύāĻা āϏেāϰা” āĻŦāϞা āĻ িāĻ āĻšāĻŦে āύা—āĻাāϰāĻŖ āĻĻুāĻোāĻ āĻ ্āϝাāύ্āĻিāĻŦাā§োāĻিāĻ, āĻিāύ্āϤু āĻāĻĒাāĻĻাāύ āĻ bacterial coverage āĻāϞাāĻĻা। āĻোāύāĻি āĻāĻĒāϝুāĻ্āϤ āĻšāĻŦে āϤা āϏংāĻ্āϰāĻŽāĻŖেāϰ āϧāϰāύ āĻ āĻĒ্āϰাāĻŖীāϰ species-āĻāϰ āĻāĻĒāϰ āύিāϰ্āĻāϰ āĻāϰে।
āĻŽূāϞ āĻĒাāϰ্āĻĨāĻ্āϝ
| āĻŦিāώ⧠| Invemox 15% LA | COMBICILLIN-LA |
|---|---|---|
| āĻĒ্āϰāϧাāύ āĻāĻĒাāĻĻাāύ | Amoxicillin 150 mg/mL | Procaine Penicillin G + Benzathine Penicillin G + Dihydrostreptomycin |
| Antibiotic class | Aminopenicillin | Penicillin + aminoglycoside |
| Long-acting | ✅ | ✅ |
| Target | Amoxicillin-sensitive bacteria | Penicillin/Dihydrostreptomycin-sensitive bacteria |
| āĻুāĻুāϰ/āĻŦিāĻĄ়াāϞ | āĻিāĻু āĻ āύুāĻŽোāĻĻিāϤ formulation-āĻ āĻāĻে | āύিāϰ্āĻĻিāώ্āĻ formulation/label āĻĻেāĻāϤে āĻšāĻŦে |
| āĻৃāĻŽি āĻŽাāϰে | ❌ | ❌ |
Invemox 15% LA-āϤে āĻĒ্āϰāϤি mL-āĻ 150 mg amoxicillin āĻĨাāĻে āĻāĻŦং āĻŦিāĻিāύ্āύ official product information-āĻ respiratory, digestive, urogenital, skin/soft-tissue bacterial infection-āĻāϰ āĻāύ্āϝ āĻāϞ্āϞেāĻ āĻāĻে। (Medicines Europe)
COMBICILLIN-LA-āϤে penicillin-āĻāϰ āϏāĻ্āĻে dihydrostreptomycin āĻāĻে āĻāĻŦং āĻĒ্āϰāϏ্āϤুāϤāĻাāϰāĻেāϰ āϤāĻĨ্āϝ āĻ āύুāϝাāϝ়ী cattle/pig-āĻāϰ āĻŦিāĻিāύ্āύ susceptible bacterial infection-āĻ āĻŦ্āϝāĻŦāĻšৃāϤ āĻšāϝ়। (Komipharm International Co., Ltd.)
đ āϝāĻĻি āĻāĻĒāύাāϰ āĻĒ্āϰāĻļ্āύāĻা āĻুāĻুāϰেāϰ āĻāύ্āϝ āĻšā§
āĻুāĻুāϰেāϰ āϏাāϧাāϰāĻŖ bacterial wound/skin/soft-tissue āĻŦা respiratory infection āĻšāϞে amoxicillin-based Invemox-āĻāϰ āĻŦ্āϝāĻŦāĻšাāϰ āĻিāĻু approved product information-āĻ āĻāĻে। āϤāĻŦে āĻāĻাāĻে āϏ্āĻŦā§ংāĻ্āϰিā§āĻাāĻŦে “āϏেāϰা” āĻŦāϞা āϝাā§ āύা—āĻাāϰāĻŖ infection-āĻāϰ bacteria āĻāĻŦং antibiotic sensitivity āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ। Invemox-āĻāϰ āĻিāĻু āĻ āύুāĻŽোāĻĻিāϤ āϤāĻĨ্āϝ āĻুāĻুāϰ āĻ āĻŦিāĻĄ়াāϞāĻে target species āĻšিāϏেāĻŦে āĻāϞ্āϞেāĻ āĻāϰে। (Medicines Europe)
āĻāϰ āϝāĻĻি āĻāĻĒāύাāϰ āĻāĻĻ্āĻĻেāĻļ্āϝ āĻšā§ āĻāĻেāϰ āĻŦāϞা āĻĒাā§āĻাāύাā§ āĻাāϞ/āĻļāϏাāϰ āĻŦীāĻেāϰ āĻŽāϤো āĻুāĻāϰা (āϏāĻŽ্āĻাāĻŦ্āϝ tapeworm segment) āĻিāĻিā§āϏা āĻāϰা, āϤাāĻšāϞে āĻĻুāĻোāϰ āĻোāύোāĻিāĻ āϏāĻ িāĻ āĻāώুāϧ āύā§। āĻāĻুāϞো antibiotic; tapeworm-āĻāϰ āĻāύ্āϝ deworming treatment āϞাāĻে।
āĻāĻĒāύি āϝāĻĻি āĻুāĻুāϰāĻিāϰ āύিāϰ্āĻĻিāώ্āĻ āϏāĻŽāϏ্āϝাāϰ āĻāύ্āϝ āĻāĻ āĻĻুāĻিāϰ āĻŽāϧ্āϝে āĻŦেāĻে āύিāϤে āĻাāύ, āĻুāĻুāϰেāϰ āĻāĻāύ, āĻŦā§āϏ, āĻী āϞāĻ্āώāĻŖ, āĻ্āώāϤ/āĻĒুঁāĻ āĻāĻে āĻি āύা āĻāĻŦং āϏāĻŽ্āĻāĻŦ āĻšāϞে āĻ্āώāϤেāϰ/āĻĒাā§āĻাāύাāϰ āĻāĻŦি āĻĻিāύ। āϏেāĻ āϤāĻĨ্āϝ āĻ āύুāϝাā§ী āĻĻুāĻিāϰ āĻĒাāϰ্āĻĨāĻ্āϝ āĻāĻŦং āĻোāύ āϧāϰāύেāϰ treatment āϏাāϧাāϰāĻŖāϤ āĻŦিāĻŦেāĻāύা āĻāϰা āĻšā§, āϏেāĻা āύিāϰ্āĻĻিāώ্āĻ āĻāϰে āĻŦāϞāϤে āĻĒাāϰāĻŦ।
āύিāĻāĻŽোāύিā§া āĻāĻ্āϰাāύ্āϤ āĻুāĻুāϰেāϰ āĻāύ্āϝ āĻļুāϧু Invemox 15% LA āĻŦāύাāĻŽ Combicillin-LA—āĻāĻ āĻĻুāĻিāϰ āĻŽāϧ্āϝে “āϏেāϰা” āĻāĻāĻি āύিāϰ্āĻĻিāώ্āĻ āĻāϰে āĻŦāϞা āύিāϰাāĻĒāĻĻ āύā§। āĻাāϰāĻŖ āύিāĻāĻŽোāύিā§াāϰ āϤীāĻŦ্āϰāϤা, āϏāĻŽ্āĻাāĻŦ্āϝ āĻীāĻŦাāĻŖু, aspiration āĻšā§েāĻে āĻি āύা āĻāĻŦং antibiotic sensitivity āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ। ISCAID-āĻāϰ canine respiratory guidelines-āĻ severity āĻ āύুāϝাā§ী āĻিāĻিā§āϏা āĻāϞাāĻĻা āĻāϰাāϰ āĻĒāϰাāĻŽāϰ্āĻļ āĻĻেā§। (PubMed Central (PMC))
āĻāĻ āĻĻুāĻিāϰ āĻ্āώেāϤ্āϰে
Invemox 15% LA = amoxicillin
COMBICILLIN-LA = penicillin + dihydrostreptomycin
āĻŽৃāĻĻু, āϏ্āĻĨিāϤিāĻļীāϞ bacterial pneumonia-āϤে oral amoxicillin-clavulanate āĻŦা doxycycline-āĻāϰ āĻŽāϤো regimen āĻŦ্āϝāĻŦāĻšাāϰেāϰ evidence āĻāĻে। (PubMed Central (PMC))
āĻিāύ্āϤু āĻļ্āĻŦাāϏāĻāώ্āĻ, āĻ্āĻŦāϰ, āĻĻুāϰ্āĻŦāϞāϤা, dehydration āĻŦা sepsis-āĻāϰ āϞāĻ্āώāĻŖāϏāĻš pneumonia āĻšāϞে guidelines āĻšাāϏāĻĒাāϤাāϞে/āĻেāĻেāϰিāύাāϰি supervision-āĻ parenteral antibiotic, āĻāĻŦং āĻুāϰুāϤāϰ āĻ্āώেāϤ্āϰে Gram-positive āĻ Gram-negative āĻāĻā§ coverage āĻŦিāĻŦেāĻāύা āĻāϰāϤে āĻŦāϞে। (PubMed Central (PMC))
āϤাāĻ Invemox 15% LA-āĻে āĻļুāϧু “amoxicillin” āĻšিāϏেāĻŦে āĻĻেāĻে severe pneumonia-āϰ āĻāύ্āϝ āύিāĻে āĻĨেāĻে āĻŦেāĻে āύেāĻā§া āĻ িāĻ āĻšāĻŦে āύা, āĻāϰ Combicillin-LA-āĻ automatically superior āύā§।
đ¨ āϝāĻĻি āĻুāĻুāϰāĻিāϰ āĻāĻāύ āύিāĻāĻŽোāύিā§া āĻĨাāĻে
āύিāĻেāϰ āϝেāĻোāύোāĻি āĻĨাāĻāϞে āĻāĻāĻ veterinary treatment āĻāϰুāϰি:
āĻŽুāĻ āĻুāϞে/āĻ āϤিāϰিāĻ্āϤ āĻĻ্āϰুāϤ āĻļ্āĻŦাāϏ āύেāĻā§া
āĻļ্āĻŦাāϏ āύিāϤে āĻŦুāĻ āĻ āĻĒেāĻ āĻুāĻŦ āĻোāϰে āĻāĻ াāύাāĻŽা āĻāϰা
āύীāϞ/āϧূāϏāϰ āĻিāĻš্āĻŦা āĻŦা āĻŽাā§ি
āĻĻাঁā§িā§ে āĻĨাāĻāϤে āύা āĻĒাāϰা/āĻ āϤ্āϝāύ্āϤ āĻĻুāϰ্āĻŦāϞ
āĻāĻ্āĻ āĻ্āĻŦāϰ
āĻাāĻā§া-āĻĒাāύি āĻŦāύ্āϧ
āĻাāĻļি āĻ āĻļ্āĻŦাāϏāĻāώ্āĻ āĻĻ্āϰুāϤ āĻŦাā§āĻে
āύিāĻāĻŽোāύিā§া life-threatening āĻšāϤে āĻĒাāϰে āĻāĻŦং āĻুāϰুāϤāϰ āĻ্āώেāϤ্āϰে antibiotic āĻļুāϰু āĻāϰাāϰ āĻĒাāĻļাāĻĒাāĻļি diagnostic testing/culture āĻāϰা āĻুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ। (PubMed Central (PMC))
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>




No comments:
Post a Comment